Patents for A61K 49 - Preparations for testing in vivo (35,376) |
---|
05/17/2007 | US20070110675 Method for predicting the developmetn of allergic disease |
05/17/2007 | US20070110674 Sono-active liposomes and lipid particles and use thereof as contrast agents and active-agent delivery systems |
05/17/2007 | US20070110673 Allergen peptide fragments and use thereof |
05/17/2007 | US20070110672 SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors |
05/17/2007 | US20070110670 Method for evaluating hair damage using an oxidized protein in hair as an indicator |
05/17/2007 | US20070110669 Methods for In Vivo Evaluation of Pulmonary Physiology And/Or Function Using NMR Signals of Polarized 129Xe |
05/17/2007 | US20070110667 Radionuclide labeling of vitamin B12 and coenzymes thereof |
05/17/2007 | US20070110666 Methods for preparation of live body tissues for examination |
05/17/2007 | US20070110665 Tissue marker for multimodality radiographic imaging |
05/16/2007 | EP1785146A2 Mr-signal emitting coatings |
05/16/2007 | EP1784647A1 Method for measuring dynamics of self-assembling systems of biological molecules in vivo and uses for discovering or evaluating therapeutic agents |
05/16/2007 | EP1784228A1 Gas-filled microvesicles composition for contrast imaging |
05/16/2007 | EP1784227A2 Mr imaging method for the discrimination between healthy and tumour tissue |
05/16/2007 | EP1784226A2 Cyanine dyes conjugated with antibodies for the diagnosis of micrometastasis |
05/16/2007 | EP1085896B1 Conformationally constrained backbone cyclized somatostatin analogs |
05/16/2007 | CN2899735Y Animal or object contamination device |
05/16/2007 | CN1965082A 人源化抗体 Humanized antibodies |
05/16/2007 | CN1964986A Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
05/15/2007 | US7217788 Controlling immunology; antiinflammatory agents |
05/15/2007 | US7217736 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
05/15/2007 | US7217694 Inhibitors of IAPP fibril formation and uses thereof |
05/15/2007 | US7217457 Mixture of hydrophobic polymer core and nanoparticles; immobilization |
05/15/2007 | US7217411 CeSERT genes, proteins, and modulatory compounds |
05/15/2007 | US7217410 Forming image of sample and coated microparticle mixture by exposing to electromagnetic radiation of infrared or ultraviolet frequency; optical coherence tomography, holography, endoscopy; light, confocal, polarization, interference, and/ormulti-photon microscopy |
05/15/2007 | CA2255540C Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
05/15/2007 | CA2149419C Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds |
05/15/2007 | CA2130452C Altered antibodies, products and processes relating thereto |
05/10/2007 | WO2007053637A2 A tumor susceptible rat with a mutation in apc gene |
05/10/2007 | WO2007051739A2 X-ray system for the creation of diagnostic x-ray images using contrast media |
05/10/2007 | WO2007009637A3 Complexes containing perfluoroalkyl, their use as contrast media for nmr, x-ray and radio diagnosis and radiotherapy |
05/10/2007 | WO2006102395A3 Delivery systems and methods for diagnosing and treating cardiovascular diseases |
05/10/2007 | WO2006101503A3 Method for screening agents against human prostate disease |
05/10/2007 | WO2006052691A3 Pet and magnetic resonance for screening alzheimer's disease therapeutics |
05/10/2007 | WO2006002873A3 1 , 4 -bis (carboxymethyl) -6- ' bis ( carboxymethyl) amino ! -6 -methyl- perhydro-1 , 4 diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri ) |
05/10/2007 | US20070107072 Transgenic amphibian models for lymphatic vessel development |
05/10/2007 | US20070105188 determining sperm quality, and different storage media's effect thereon; male fertility |
05/10/2007 | US20070105167 Virulence Associated Nucleic Acid Sequences and Uses Thereof |
05/10/2007 | US20070105147 Rapid method for screening compounds for in vivo activity |
05/10/2007 | US20070104658 Preparing spray-dried particles having a tap density of less than about 0.4 g/cm3 and have a hydrophobic amino acid and a therapeutic, prophylactic or diagnostic agent; pulmonary delivery; respiratory disorders |
05/10/2007 | US20070104650 magnetic resonance imaging; labeling cells with first contrast agent (iron oxide) with magnetic susceptibility sufficient to induce magnetic field inhomogeneity in water molecules, implanting cells in body, obtaining signals, administering second contrast agent (gadolinium), obtaining signals |
05/10/2007 | US20070104649 Optically fluorescent nanoparticles |
05/10/2007 | US20070104648 Compositions, methods of preparing amino acids, and nuclear magnetic resonance spectroscopy |
05/10/2007 | US20070104644 Inhibitor imaging agents |
05/09/2007 | EP1782845A1 Bone cement and X-ray contrast agent and methods of manufacturing the same |
05/09/2007 | EP1781284A1 Use of the combination comprising temozolomide and tnf-alpha for treating glioblastoma |
05/09/2007 | EP1781170A1 Adduct of fluorescent dye and tumor avid tetrapyrrole |
05/09/2007 | CN1960754A Cancer regulation antibody |
05/09/2007 | CN1960707A Liposomal assembly for therapeutic and/or diagnostic use |
05/09/2007 | CN1958076A Emulsion spray drying method for preparing ultrasound microbubble contrast agent in batch |
05/09/2007 | CN1314704C Oligopeptide suppressor of matrix metalloprotease 2 |
05/09/2007 | CN1314659C Method for preparing ioxitalamic acid |
05/09/2007 | CN1314455C Bone powder mixture and X-ray contras-medium and producing method thereof |
05/09/2007 | CN1314454C Duplication method of chmice acute hyperuricemia model |
05/08/2007 | CA2267498C Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
05/08/2007 | CA2230406C Antimicrobial caries-detecting composition |
05/03/2007 | WO2007051068A2 Compositions and methods for the treatment of aberrant stress response disorders |
05/03/2007 | WO2007050581A2 An albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use |
05/03/2007 | WO2007050281A2 Method for indicating shelf-life after mixing pre-dosed, pre-packaged two-part dental compositions |
05/03/2007 | WO2007049264A2 Assays using nanoparticles |
05/03/2007 | WO2007048856A1 Persistent luminescence nanoparticles used in the form of a diagnosis agent for in vivo optical imaging |
05/03/2007 | WO2006102536A3 Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth |
05/03/2007 | WO2002081649A3 ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF |
05/03/2007 | US20070099185 Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein |
05/03/2007 | US20070098643 Oligomers of gadolinium chelates, their applicationascontrast products in magnetic resonance imaging and their synthesis intermediates |
05/03/2007 | US20070098642 Nanoparticle-based imaging agents for X-ray/computed tomography |
05/03/2007 | US20070098641 Nanoparticle-based imaging agents for X-ray/computed tomography |
05/03/2007 | US20070098640 Nanoparticle-based imaging agents for X-ray/computed tomography |
05/03/2007 | US20070098639 Process for the Preparation of Coated Polymer Particles |
05/03/2007 | US20070098638 Macrocyclic cyanine and indocyanine bioconjugates provide improved biomedical applications |
05/03/2007 | US20070098637 tissue regeneration using tumors as a source of signals; regenerative potential of the cellular components of arteries, veins, and nerves; tissue engineering |
05/03/2007 | US20070098636 Method of identifying responders to treatment with insulin sensitizers |
05/03/2007 | US20070098635 Secreted polypeptide species associatedwith cardiovascular disorders |
05/03/2007 | US20070098631 Diagnostic compounds comprising a scaffold coupled to a signal entity for medical imaging diagnostic |
05/03/2007 | CA2627287A1 Persistent luminescence nanoparticles used in the form of a diagnosis agent for in vivo optical imaging |
05/03/2007 | CA2627155A1 An albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use |
05/02/2007 | EP1778858A2 High throughput pharmaceutical screening using drosophila |
05/02/2007 | EP1778651A2 Multivalent chelators for modifying and organizing of target molecules |
05/02/2007 | EP1778299A2 Methods for preparing multivalent constructs for therapeutic and diagnostic applications |
05/02/2007 | EP1778298A2 Lipoprotein nanoplatforms |
05/02/2007 | EP1778274A2 Modulation of fiaf and the gastrointestinal microbiota |
05/02/2007 | EP1778159A1 Plural activating optical change toothpastes, stimuli and elements |
05/02/2007 | EP1778082A1 Carboranylporphyrins and uses thereof |
05/02/2007 | EP1519756B1 Use of metal complexes containing perfluoroalkyl as contrast agents in magnetic resonance imaging for representing intravascular thrombi |
05/02/2007 | EP1480979B1 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates |
05/02/2007 | EP1470127B1 N, n'-dimethylated n-confused porphyrins |
05/02/2007 | EP1135531B1 Methods for introducing heterologous cells into fish |
05/02/2007 | EP1033137B1 Diagnostic reagent for complications associated with diabetes or renal failure |
05/02/2007 | CN1956738A Antibodies to MAdCAM |
05/02/2007 | CN1956678A Optical sensor for in vivo detection of analyte |
05/02/2007 | CN1954888A Chinese medicine capsule for stomach ultrasonic image |
05/02/2007 | CN1954887A Preparation method of screening mould of external anti-tumor medicine |
05/02/2007 | CN1313160C Doped cerium alkaline earth hafnium dioxide scintillator and mfg. method thereof |
05/01/2007 | US7211659 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
05/01/2007 | US7211401 Method for the detection of prion diseases |
05/01/2007 | US7211241 Cascade polymer complexes that contain complexing ligands of general formula I A-(X (Y-(Z-(W KW)Z)y)x) (I), in which A stands for a nitrogen-containing cascade nucleus of base multiplicity a, X and Y, independently of one another, stand |
05/01/2007 | US7211240 Multivalent constructs for therapeutic and diagnostic applications |
04/26/2007 | WO2007047815A2 Diagnosis of transmissible spongiform encephalopathy |
04/26/2007 | WO2007047668A2 Use of non-canonical amino acids as metabolic markers for rapidly-dividing cells |
04/26/2007 | WO2007047141A2 Transgenic ro s a26-luc i f eras e mice for bioluminescent imaging |
04/26/2007 | WO2007045903A2 Methods of analysing cell behaviour |